{"SPADE_UN_15442": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15442", "Peptide Name": "ZXR-2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "FKIGGFIKKLWRSLLA", "Sequence Length": 16, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:PC-3 (IC50=14.2±0.5 µM); PC-3 (IC50=14.8±1.6 μM ); Hep-G2 (IC50=7.5±1.2 µM); HeLa (IC50=8.1±1.6 µM); HeLa (IC50=8.1±1.6 μM ); Huh-7 (IC50=8.4±1.1 µm); SACC-83 (IC50=9.9±1.7 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "HEK293T:IC50=6.3±0.7 µM; WPMY-1:IC50=12.4±2.0 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C93H149N23O18", "Mass": 1877.32, "PI": 11.26, "Net Charge": 4, "Hydrophobicity": 0.57, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Comments": "ZXR-2 could cause cell membrane lysis", "Literature": [{"Title": "From a pro-apoptotic peptide to a lytic peptide One single residue mutation", "Pubmed ID": "27207743", "Reference": "Biochim Biophys Acta. 2016 Aug;1858(8)1914-25.", "Author": "Zhou XR, Zhang Q, Tian XB, Cao YM, Liu ZQ, Fan R, Ding XF, Zhu Z, Chen L, Luo SZ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=27207743"}], "Frequent Amino Acids": "KLF", "Absent Amino Acids": "CDEHMNOPQTUVY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 6, "Positive Residues": 4, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_21324", "Similarity": 1.0, "Sequence": "WFKIIKK"}, {"SPADE_ID": "SPADE_N_08299", "Similarity": 1.0, "Sequence": "SLLAKIDCGGACKARCRLSSRPHLCKRACGTCCQRCSCVPPGTAGNYDVCPCYATLTTHGGKRKCP"}, {"SPADE_ID": "SPADE_UN_12760", "Similarity": 1.0, "Sequence": "SLLALIRKLLT"}]}}}